{"blood cholesterol increased": 3.48, "blood thyroid stimulating hormone increased": 7.29, "blood triglycerides increased": 3.37, "cardiac failure": 4.26, "death": 6.57, "decreased appetite": 2.4, "dementia": 3.02, "dermatitis allergic": 2.37, "dermatitis exfoliative": 14.03, "dermatitis exfoliative generalised": 16.43, "disease progression": 3.3, "drug eruption": 13.84, "drug reaction with eosinophilia and systemic symptoms": 10.96, "dry skin": 3.4, "dysphagia": 3.3, "eczema": 3.22, "eosinophil count increased": 7.29, "erythema multiforme": 8.98, "fall": 2.7, "hospitalisation": 2.12, "hot flush": 8.41, "hypertension": 2.76, "hypothyroidism": 11.04, "interstitial lung disease": 11.43, "metastases to bone": 15.51, "metastases to lymph nodes": 7.7, "oedema peripheral": 2.43, "prescribed underdose": 9.1, "prostate cancer": 4.11, "prostate cancer metastatic": 197.81, "prostatic specific antigen increased": 81.18, "rash": 15.36, "rash erythematous": 3.65, "rash maculo-papular": 9.66, "rash papular": 2.33, "rash pruritic": 8.71, "skin disorder": 3.01, "skin exfoliation": 3.73, "skin reaction": 6.02, "skin toxicity": 13.66, "stevens-johnson syndrome": 9.19, "surgery": 2.26, "therapeutic product effect incomplete": 3.41, "toxic epidermal necrolysis": 15.69, "toxic skin eruption": 4.53, "treatment noncompliance": 4.79}